Harpoon Therapeutics, Inc.
HARP
Revenue
4.45M
▼-15.77M▼-78.00%
3 Months ChangeAssets
47.58M
▼-15.62M▼-24.72%
3 Months ChangeLiabilities
43.04M
▼-17.16M▼-28.51%
3 Months ChangeFree Cash Flow
-19.29M
▲5.36M▲21.73%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-03-11
Form 8-K
ID: 0001193125-24-064395
2024-03-08
Form 8-K
ID: 0001193125-24-063629
2024-02-28
Form 8-K
ID: 0001193125-24-049205
2024-02-22
Form 8-K
ID: 0001193125-24-042133
2024-01-29
Form 8-K
ID: 0001193125-24-018159
2024-01-26
Form 8-K
ID: 0001193125-24-015670
2024-01-08
Form 8-K
ID: 0001193125-24-003927
2023-11-28
Form 8-K
ID: 0001193125-23-284289
2023-11-24
Form 8-K
ID: 0001193125-23-282726
2023-11-09
Form 10-Q
ID: 0000950170-23-062125